/
/
En hög kapacitet Kompatibel analys för att utvärdera läkemedlets effektivitet mot makrofag passe<em> Mycobacterium tuberculosis</em
JoVE 비디오를 활용하시려면 도서관을 통한 기관 구독이 필요합니다. 전체 비디오를 보시려면 로그인하거나 무료 트라이얼을 시작하세요.
Chapters
- 00:05Title
- 00:46Infection Protocol to Generate Mtb/Macrophage Aggregate Structures
- 04:04Growth Inhibition Assay to Assess Drug Efficacy against Mtb Derived from Mtb/Macrophage Aggregates
- 06:31Quantification of Drug Efficacy Using the Resazurin Microtiter Assay
- 07:54Using the Resazurin Microtiter Assay to Measure Mtb Viability
- 09:52Conclusion
New models and assays that would improve the early drug development process for next-generation anti-tuberculosis drugs are highly desirable. Here, we describe a quick, inexpensive, and BSL-2 compatible assay to evaluate drug efficacy against Mycobacterium tuberculosis that can be easily adapted for high-throughput screening.
